AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Jupiter Neurosciences Inc... (JUNS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.07

0.10 (10.33%)

At close: Feb 04, 2025, 3:59 PM

1.05

-1.79%

After-hours Feb 04, 2025, 07:29 PM EST

undefined% (undefined)

Bid	1.05
Market Cap	35.42M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.02
PE Ratio (ttm)	-53.5
Forward PE	n/a
Analyst	n/a

Ask	1.09
Volume	749,756
Avg. Volume (20D)	1,064,880
Open	1.00
Previous Close	0.97
Day's Range	0.93 - 1.10
52-Week Range	0.91 - 19.51
Beta	undefined

About JUNS

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Jan 18, 2022

Employees 4

Stock Exchange NASDAQ

Ticker Symbol JUNS

Website https://www.jupiterorphan.com